Journal of Hepatocellular Carcinoma
Volume 10, 2023 - Issue
REVIEW
Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma
Valentina Zanuso1 Department of Biomedical Sciences, Humanitas University, Milan, Italy;2 Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Milan, Italy
https://orcid.org/0000-0003-4308-6601View further author information
https://orcid.org/0000-0003-4308-6601View further author information, Angelo Pirozzi1 Department of Biomedical Sciences, Humanitas University, Milan, Italy;2 Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Milan, Italyhttps://orcid.org/0000-0001-8603-0312View further author information
https://orcid.org/0000-0001-8603-0312View further author information, , Tiziana Pressiani2 Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Milan, Italyhttps://orcid.org/0000-0001-6919-1536View further author information
https://orcid.org/0000-0001-6919-1536View further author information & Lorenza Rimassa1 Department of Biomedical Sciences, Humanitas University, Milan, Italy;2 Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Milan, ItalyCorrespondence[email protected]
https://orcid.org/0000-0001-9957-3615View further author information
https://orcid.org/0000-0001-9957-3615View further author information